Skip to content
The Policy VaultThe Policy Vault

EysuvisBlue Cross Blue Shield of Texas

dry eye disease

Approval duration

BCBSIL: 12 months; all other plans: Initial—Cequa, Xiidra, Vevye, Eysuvis 3 months; Restasis/cyclosporine 6 months; Tyrvaya, Miebo 2 months; Renewal—Eysuvis 3 months, all others 12 months